Director Discovery Process And Analytical Development
Esobiotec
12+ years postgraduate industry experience
Lentiviral vector manufacturing expertise
Early process and analytical development leadership
This role involves leading the strategy and execution of early process development and analytical methods for novel in vivo lentiviral vectors to enable high-quality discovery and preclinical translation
Job Summary
This role involves leading the strategy and execution of early process development and analytical methods for novel in vivo lentiviral vectors to enable high-quality discovery and preclinical translation.
The successful candidate will adapt production from discovery to small bioreactor manufacturing while engineering new production cell lines and defining bespoke analytical testing protocols.
As a proud member of the AstraZeneca group, Esobiotec offers a dynamic environment where scientific passion drives real-world impact on life-changing treatments.
Matching Summary
This role involves leading the strategy and execution of early process development and analytical methods for novel in vivo lentiviral vectors to enable high-quality discovery and preclinical translation.
Skills & Requirements
Must-have
12+ years postgraduate industry experience
Lentiviral vector manufacturing expertise
Early process and analytical development leadership
GMP manufacturing and analytical development
CDMO oversight and management experience
Nice-to-have
Passion for gene therapy innovation
Strong stakeholder communication skills
Collaborative cross-functional team approach
Experience with viral vector CMC guidelines
Key Requirements
MSc or PhD in Virology, Biochemistry, Cell Biology, Molecular Biology, Biomedical Engineering, or related discipline
12+ years of postgraduate industry experience in manufacturing including GMP
Proven track record leading process and analytical development teams
Familiarity with CMC regulatory guidelines for gene or cell therapy products
Solid experience managing vector manufacturing with external CDMOs